Lataa...

Sorafenib/Regorafenib and Lapatinib interact to kill CNS tumor cells

The present studies were to determine whether the multi-kinase inhibitor sorafenib or its derivative regorafenib interacted with the ERBB1/ERBB2 inhibitor lapatinib to kill CNS tumor cells. In multiple CNS tumor cell types sorafenib and lapatinib interacted in a greater than additive fashion to caus...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hamed, Hossein A., Tavallai, Seyedmehrad, Grant, Steven, Poklepovic, Andrew, Dent, Paul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4182138/
https://ncbi.nlm.nih.gov/pubmed/24911215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.24689
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!